Michał Mikuła

SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains

Tomasz Rzymski, Michał Mikuła, Eliza Żyłkiewicz et al. · Oncotarget · 2017 · 98 citations · Full text

Immunology, Lineage Commitment, Cancer Biology +17

Landscape of the hnRNP K protein–protein interactome

Michał Mikuła, Artur Dzwonek, Jakub Karczmarski et al. · PROTEOMICS · 2006 · 86 citations

Signal Transduction, Interactomics, Medicine +13

Quantitative detection for low levels of Helicobacter pylori infection in experimentally infected mice by real-time PCR

Michał Mikuła, Artur Dzwonek, Elżbieta Katarzyna Jagusztyn-Krynicka et al. · Journal of Microbiological Methods · 2003 · 73 citations

Pathogen Detection, Real-time Pcr, Pathogenesis +10

Serine Biosynthesis Pathway Supports MYC–miR-494–EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells

Emilia Białopiotrowicz, Monika Noyszewska‐Kania, Neli Kachamakova‐Trojanowska et al. · Cancers · 2020 · 63 citations · Full text

Synthetic lethality between <i> <scp>VPS</scp> 4A </i> and <i> <scp>VPS</scp> 4B </i> triggers an inflammatory response in colorectal cancer

Ewelina Szymańska, Paulina Nowak, Krzysztof Kolmus et al. · EMBO Molecular Medicine · 2020 · 48 citations · Full text